Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

Clicks: 259
ID: 111573
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #39 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In low-income countries, children ≥4 years and adults with low CD4 count have equally high mortality risk in the 3 months after initiation of antiretroviral the
Reference Key
sarah2012clinicalmortality Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Walker, A. Sarah;Prendergast, Andrew J.;Mugyenyi, Peter;Munderi, Paula;Hakim, James;Kekitiinwa, Addy;Katabira, Elly;Gilks, Charles F.;Kityo, Cissy;Nahirya-Ntege, Patricia;Nathoo, Kusum;Gibb, Diana M.;for the DART and ARROW trial teams;
Journal clinical infectious diseases
Year 2012
DOI
DOI not found
URL
https://academic.oup.com/cid/article/55/12/1707/461350?searchresult=1#supplementary-data
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult adolescent aged middle aged Child Infant preschool hiv infections / epidemiology uganda / epidemiology risk hiv infections / mortality* cd4 lymphocyte count pmid:22972859 pmc3501336 doi:10.1093/cid/cis797 a sarah walker andrew j prendergast dart and arrow trial teams anti-retroviral agents / therapeutic use* hiv infections / drug therapy* kaplan-meier estimate

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.